Limited Availability of Ambrosia Allergy Immunotherapy Leaves Serbian Patients Vulnerable During Peak Season

With ambrosia pollen concentrations currently soaring, roughly 30 percent of Serbia's population experiences respiratory allergies, yet many face significant barriers to accessing targeted immunotherapy treatments.